Logo image of ORGN

ORIGIN MATERIALS INC (ORGN) Stock Fundamental Analysis

NASDAQ:ORGN - US68622D1063 - Common Stock

0.5348 USD
-0.03 (-5.58%)
Last: 8/29/2025, 8:00:02 PM
0.56 USD
+0.03 (+4.71%)
After Hours: 8/29/2025, 8:00:02 PM
Fundamental Rating

2

Taking everything into account, ORGN scores 2 out of 10 in our fundamental rating. ORGN was compared to 83 industry peers in the Chemicals industry. The financial health of ORGN is average, but there are quite some concerns on its profitability. ORGN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ORGN has reported negative net income.
In the past year ORGN has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: ORGN reported negative net income in multiple years.
ORGN had a negative operating cash flow in each of the past 5 years.
ORGN Yearly Net Income VS EBIT VS OCF VS FCFORGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

ORGN's Return On Assets of -25.68% is on the low side compared to the rest of the industry. ORGN is outperformed by 88.10% of its industry peers.
ORGN's Return On Equity of -28.76% is on the low side compared to the rest of the industry. ORGN is outperformed by 75.00% of its industry peers.
Industry RankSector Rank
ROA -25.68%
ROE -28.76%
ROIC N/A
ROA(3y)-0.36%
ROA(5y)-11.35%
ROE(3y)0.58%
ROE(5y)-6056.88%
ROIC(3y)N/A
ROIC(5y)N/A
ORGN Yearly ROA, ROE, ROICORGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K

1.3 Margins

ORGN has a worse Gross Margin (1.28%) than 89.29% of its industry peers.
ORGN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 1.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ORGN Yearly Profit, Operating, Gross MarginsORGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

4

2. Health

2.1 Basic Checks

ORGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
ORGN has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, ORGN has a worse debt to assets ratio.
ORGN Yearly Shares OutstandingORGN Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M
ORGN Yearly Total Debt VS Total AssetsORGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

ORGN has an Altman-Z score of 0.82. This is a bad value and indicates that ORGN is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ORGN (0.82) is worse than 79.76% of its industry peers.
ORGN has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
ORGN has a Debt to Equity ratio of 0.01. This is amongst the best in the industry. ORGN outperforms 92.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 0.82
ROIC/WACCN/A
WACC10.11%
ORGN Yearly LT Debt VS Equity VS FCFORGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

ORGN has a Current Ratio of 6.37. This indicates that ORGN is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 6.37, ORGN belongs to the top of the industry, outperforming 96.43% of the companies in the same industry.
ORGN has a Quick Ratio of 6.33. This indicates that ORGN is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 6.33, ORGN belongs to the best of the industry, outperforming 96.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.37
Quick Ratio 6.33
ORGN Yearly Current Assets VS Current LiabilitesORGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

3

3. Growth

3.1 Past

ORGN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -466.67%.
ORGN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.84%.
EPS 1Y (TTM)-466.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.71%
Revenue 1Y (TTM)-15.84%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-58.69%

3.2 Future

The Earnings Per Share is expected to grow by 16.99% on average over the next years. This is quite good.
The Revenue is expected to grow by 87.52% on average over the next years. This is a very strong growth
EPS Next Y10.75%
EPS Next 2Y15.81%
EPS Next 3Y17.39%
EPS Next 5Y16.99%
Revenue Next Year46.92%
Revenue Next 2Y89.65%
Revenue Next 3Y96.88%
Revenue Next 5Y87.52%

3.3 Evolution

ORGN Yearly Revenue VS EstimatesORGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
ORGN Yearly EPS VS EstimatesORGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ORGN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ORGN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ORGN Price Earnings VS Forward Price EarningsORGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ORGN Per share dataORGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5 2

4.3 Compensation for Growth

ORGN's earnings are expected to grow with 17.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.81%
EPS Next 3Y17.39%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ORGN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ORIGIN MATERIALS INC

NASDAQ:ORGN (8/29/2025, 8:00:02 PM)

After market: 0.56 +0.03 (+4.71%)

0.5348

-0.03 (-5.58%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-14 2025-08-14/amc
Earnings (Next)11-12 2025-11-12/amc
Inst Owners14.87%
Inst Owner Change-20.73%
Ins Owners4.63%
Ins Owner Change10.48%
Market Cap80.17M
Analysts82.86
Price Target2.04 (281.45%)
Short Float %2.23%
Short Ratio2.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-47.06%
Min EPS beat(2)-96.08%
Max EPS beat(2)1.96%
EPS beat(4)2
Avg EPS beat(4)-27.01%
Min EPS beat(4)-96.08%
Max EPS beat(4)19.79%
EPS beat(8)5
Avg EPS beat(8)25.1%
EPS beat(12)9
Avg EPS beat(12)67.73%
EPS beat(16)13
Avg EPS beat(16)134.44%
Revenue beat(2)0
Avg Revenue beat(2)-81.07%
Min Revenue beat(2)-81.71%
Max Revenue beat(2)-80.43%
Revenue beat(4)0
Avg Revenue beat(4)-41.42%
Min Revenue beat(4)-81.71%
Max Revenue beat(4)-0.43%
Revenue beat(8)3
Avg Revenue beat(8)-16.47%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)60%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.8
P/FCF N/A
P/OCF N/A
P/B 0.26
P/tB 0.26
EV/EBITDA N/A
EPS(TTM)-0.51
EYN/A
EPS(NY)-0.32
Fwd EYN/A
FCF(TTM)-0.38
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS0.19
BVpS2.08
TBVpS2.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.68%
ROE -28.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 1.28%
FCFM N/A
ROA(3y)-0.36%
ROA(5y)-11.35%
ROE(3y)0.58%
ROE(5y)-6056.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 204.39%
Cap/Sales 77.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.37
Quick Ratio 6.33
Altman-Z 0.82
F-Score3
WACC10.11%
ROIC/WACCN/A
Cap/Depr(3y)4824.97%
Cap/Depr(5y)3442.25%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-466.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.71%
EPS Next Y10.75%
EPS Next 2Y15.81%
EPS Next 3Y17.39%
EPS Next 5Y16.99%
Revenue 1Y (TTM)-15.84%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-58.69%
Revenue Next Year46.92%
Revenue Next 2Y89.65%
Revenue Next 3Y96.88%
Revenue Next 5Y87.52%
EBIT growth 1Y0.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year36.46%
EBIT Next 3Y14.85%
EBIT Next 5Y43.23%
FCF growth 1Y70%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.59%
OCF growth 3YN/A
OCF growth 5YN/A